We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (MBL-HCV1)

This study has been terminated.
(The study was terminated due to funding constraints)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01532908
First Posted: February 15, 2012
Last Update Posted: April 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
MassBiologics
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 27, 2015
  Primary Completion Date: August 27, 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: July 13, 2016